收藏切换
Advances and perspectives of modern imaging technologies in the in vivo fate of nanomedicines
收藏切换
Shuo DONG1, 2, Zhi-nan LI1, 2, Yan CHEN1, 2, *, Xiao-qi LI1, 2, *
Acta Pharmaceutica Sinica | 2026, 61(4) : 1120 - 1133
Less
收藏切换
Acta Pharmaceutica Sinica | 2026, 61(4): 1120-1133
• Reviews •
Advances and perspectives of modern imaging technologies in the in vivo fate of nanomedicines
Full
Shuo DONG1, 2, Zhi-nan LI1, 2, Yan CHEN1, 2, *, Xiao-qi LI1, 2, *
Affiliations
  • 1Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China
  • 2Multi-component of Traditional Chinese Medicine and Microecology Research Center, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing 210028, China
Published: 2026-04-12 doi: 10.16438/j.0513-4870.2025-0785
Outline
收藏切换

The elusive in vivo fate of nanomedicines represents a critical barrier to their clinical translation. Recent rapid advancements in imaging technologies, such as fluorescence imaging (FLI), photoacoustic imaging (PAI), radionuclide imaging (RI), magnetic resonance imaging (MRI), and multimodal imaging (MI) have provided powerful tools for real-time and in situ analysis of nanomedicine behavior in vivo, encompassing morphological evolution, drug release kinetics, distribution, metabolic and so on. However, significant challenges persist, particularly in continuously tracking dynamic morphological changes throughout their entire lifecycle and achieving accurate quantitative analysis within the physiological microenvironment. This review focuses on recent progress in understanding the in vivo fate of nanomedicines, systematically summarizing the fundamental principles, applications, advantages and limitations of these imaging technologies. It also highlights recent breakthroughs in utilizing these technologies to decipher the in vivo fate of nanomedicines and explores future perspectives, such as the development of innovative probes and the integration of multimodal imaging platforms. The objective is to offer robust theoretical and technical foundations for optimizing the design of nanodrug delivery systems and promoting their clinical translation.

nanomedicine  /  in vivo fate  /  drug delivery  /  imaging technique  /  clinical translation
董硕, 李智楠, 陈彦, 李晓琦. 现代成像技术在纳米制剂体内命运研究中的应用进展及展望. 药学学报, 2026 , 61 (4) : 1120 -1133 . DOI: 10.16438/j.0513-4870.2025-0785
Shuo DONG, Zhi-nan LI, Yan CHEN, Xiao-qi LI. Advances and perspectives of modern imaging technologies in the in vivo fate of nanomedicines[J]. Acta Pharmaceutica Sinica, 2026 , 61 (4) : 1120 -1133 . DOI: 10.16438/j.0513-4870.2025-0785
Year 2026 volume 61 Issue 4
208
96
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0785
  • Receive Date:2025-07-08
  • Online Date:2026-09-21
  • Published:2026-04-12
Article Data
Affiliations
History
  • Received:2025-07-08
  • Revised:2025-12-02
Affiliations
    1Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China
    2Multi-component of Traditional Chinese Medicine and Microecology Research Center, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing 210028, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0785
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT